AMARIN CORP PLC\UK Operating Leases, Future Minimum Payments, Due in Five Years
AMARIN CORP PLC\UK (AMRN) had Operating Leases, Future Minimum Payments, Due in Five Years of $0 as of 2014-12-31, per its 10-K filed 2015-03-03.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2015-03-03
- 2014-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $0.00.
- 2013-12-31: Operating Leases, Future Minimum Payments, Due in Five Years $172.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-03 |
| 2013-12-31 | $172.00K 10-K · filed 2014-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |